This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Saint Louis University. Active years: 1999-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- St. Louis, MO (US) (1999 - 2000)
- Saint Louis, MO (US) (2007 - 2009)
Company Filing History:
Years Active: 1999-2009
Title: Ranjit Ray: Innovator in Hepatitis C Research
Introduction
Ranjit Ray is a prominent inventor based in Saint Louis, MO (US), known for his significant contributions to the field of hepatitis C research. With a total of 4 patents, he has made strides in developing methods and compositions that advance the understanding and treatment of liver diseases.
Latest Patents
One of Ranjit Ray's latest patents is titled "Compositions and methods for generation of infectious hepatitis C virus in immortalized human hepatocytes." This invention provides a cell line capable of producing infectious hepatitis C virus 1a (HCV 1a) particles in culture. The patent discloses compositions and methods for an HCV 1a (clone H77) transfected immortal human hepatocyte (IHH) that can generate infectious HCV 1a virus particles. Additionally, it outlines methods for using the cell line or HCV 1a virus particles derived from it to screen for potential therapeutic agents that interfere with HCV 1a virus propagation, aiming to treat hepatic disease.
Another notable patent is the "Method of manufacturing a stellate cell death factor." This invention provides compositions and methods for selectively inhibiting the proliferation of stellate cells, which play a crucial role in the development of liver fibrosis following liver injury. The patent describes conditioned media from immortalized hepatocytes as containing a death factor that induces apoptosis of activated liver stellate cells. This pro-apoptotic activity is associated with an 80 kDa protein linked to a fetuin peptide sequence and an albumin peptide sequence.
Career Highlights
Ranjit Ray is affiliated with Saint Louis University, where he conducts his research and develops his innovative solutions. His work has garnered attention in the scientific community, contributing to advancements in liver disease treatment.
Collaborations
Ranjit Ray has collaborated with notable colleagues, including Robert B Belshe and Ratna Ray, enhancing the impact of his research through shared expertise and insights.
Conclusion
Ranjit Ray's innovative work in hepatitis C research exemplifies the importance of scientific inquiry in addressing complex health challenges. His patents reflect a commitment to advancing medical knowledge and improving therapeutic options for liver diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile